Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Feasibility of Xenon in CABG Surgery (CArDiAX)
NCT01285271Phase 3Completed
- Sponsor
- RWTH Aachen University
- Start
- May 2011
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of xenon in coronary artery disease (CAD), sponsored by RWTH Aachen University. Started May 2011; status: completed.
02
Drugs
xenon
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01285271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285271.